Searched for
ERLOTINIB TABLETS
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lessonPharma is one sector, where literally every company in the sector has gone through a phase where it is forced to have a look at its own bus...
- Alembic Pharma gets USFDA nod for cancer treatment drugThe company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) fo...
- Market Movers: Private banks, Oberoi Realty soar; investors make Rs 3L crHere is a lowdown of the movers and shakers of Friday’s session on Dalal Street.
- Cipla's U-turn: Happily ever after?In a foes-turn-friends move announced on February 27, the Mumbai-based drug maker announced that it will partner Swiss biotech company Roch...
- Roche and Cipla enter talks to settle Erlotinib patent rowThe development comes after a division bench of the Delhi HC referred the companies to a mediation that both firms chose to accept.
- Cipla slashes prices of 3 cancer drug by up to 63%The company said on Thursday that its lung cancer drug Erlocip would cost Rs 9,900 for 30 tablets instead of Rs 27,000 and Rs 3,700 for 10 ...
- Court asks Matrix not to sell generic of Roche’s cancer drugThe Madras High Court (HC) has asked Hyderabad-based Matrix Laboratories not to make or sell the generic version of Swiss major Roche’s can...
- Cipla gets relief as SC rejects Roche pleaThe Supreme Court on Friday rejected Swiss drugmaker Roche’s petition to stop Indian firm Cipla from selling the generic version of its can...
- Natco plans copy of Roche cancer drugSome more good news could be around the corner for cancer patients and healthcare groups campaigning for access to cheaper medicines. A sec...
- Cipla scores a generic win over RocheThe Delhi HC rejected an injunction plea by Swiss drug major Roche to prevent Cipla from manufacturing generic versions of anti-cancer drug...
- Delhi HC refuses relief to Swiss Company La Roche against CiplaThe Delhi High Court has refused to grant relief to Swiss pharma company Hoffmann La Roche, which sought restraining Cipla from manufacturi...
Load More
